Adele Marrangoni

2.7k citations
28 papers · 2.1k · h-index 22

Impact in

    • Ovarian cancer diagnosis and treatment
  • Oncology top 5%
    • Cancer Cells and Metastasis
    • Chemokine receptors and signaling
    • Cytokine Signaling Pathways and Interactions

Papers in

    • Advanced Biosensing Techniques and Applications 3
    • Cell death mechanisms and regulation 2
    • Glycosylation and Glycoproteins Research 1
    • Cancer Cells and Metastasis 3
    • Chemokine receptors and signaling 3

Adele Marrangoni

28 papers receiving 2.0k citations

Peers

Adele Marrangoni
Comparison fields: 5 of 104
  • Reproductive Medicine 318
  • Oncology 723
  • Cancer Research 292
  • Immunology 348
  • Obstetrics and Gynecology 78
Replace Brian M. Nolen with:
Brian M. Nolen United States
Zoya R. Yurkovetsky United States
Sanaz Memarzadeh United States
Marta Herreros‐Villanueva Spain
Rebecca Kristeleit United Kingdom
Anne M. Øyan Norway
Stefanie Avril United States
Paula R. Pohlmann United States
Elisabeth Mueller‐Holzner Austria
Adele Marrangoni relative to Brian M. Nolen United States Brian M. Nolen's profile →
Citations per field
00.5×1.6×
Brian M. Nolen · 1×
Citations per year

Countries citing papers authored by Adele Marrangoni

Since Specialization
Citations

This map shows the geographic impact of Adele Marrangoni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adele Marrangoni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adele Marrangoni more than expected).

Fields of papers citing papers by Adele Marrangoni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adele Marrangoni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adele Marrangoni. The network helps show where Adele Marrangoni may publish in the future.

Co-authors

The 25 scholars most cited alongside Adele Marrangoni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Adele Marrangoni Line = papers co-authored together Adele Marrangoni links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008359
2 2005237
3 2007176
4 2010131
5 2009130
6 2006118
7 2007104
8 201195
9 200788
10 200985
11 201280
12 200859
13 200351
14 201144
15 200841
16 201433
17 200833
18 200931
19 201030
20 200526

About Adele Marrangoni

Adele Marrangoni is a scholar working on Molecular Biology, Oncology, Reproductive Medicine, Spectroscopy and Immunology, having authored 28 papers that have together received 2.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Cancer Cells and Metastasis (3 papers), Advanced Biosensing Techniques and Applications (3 papers), Chemokine receptors and signaling (3 papers), Cell death mechanisms and regulation (2 papers), Head and Neck Cancer Studies (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Reproductive Medicine (318 citations), Oncology (723 citations), Cancer Research (292 citations), Immunology (348 citations) and Obstetrics and Gynecology (78 citations). Adele Marrangoni has collaborated with scholars based in United States, Japan and Sweden. Frequent co-authors include Anna Lokshin, Elieser Gorelik, Vera Levina, Lyudmila Velikokhatnaya, Brian M. Nolen, Richard DeMarco, Matthew Winans, Zoya R. Yurkovetsky, Ronald B. Herberman and Douglas Landsittel. Their work appears in journals such as Gynecologic Oncology, Cancer Epidemiology Biomarkers & Prevention, Cancer Research, Clinical Cancer Research and Cancer Biomarkers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact